CIVBX:NASDAQ
American Funds International Vantage Fund Class 529-C – CIVBX Fund Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|
17.34 | 0.03 (+0.17%) | 15.96 - 18.00 | 0.0 |
Market data as of 12:00AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - CIVBX
The investment seeks to provide prudent growth of capital and conservation of principal.
The fund invests primarily in common stocks of issuers outside of the United States that the investment adviser believes have the potential for growth, many of which have the potential to pay dividends. Under normal market conditions, it invests at least 80% of its net assets in equity-type securities and at least 80% of its net assets in securities of issuers outside the United States. The fund may invest up to 10% of its net assets in the securities of issuers based in emerging markets.
Growth of $10,000 (10 Years)
Total Return | 5.33% |
---|
Yield (Trailing 12 Mo.) | 0.32% |
---|
Expense Ratio | 1.74% |
---|
Front Load | None |
---|
Deferred Load | 1.00% |
---|
Minimum Investment | $250.00 |
---|
Management Tenure | 14 Years |
---|
Fund Inception | 11/08/2019 |
---|
Trailing Total Returns - CIVBX
as of 02/28/2025
Timeframe | CIVBX | S&P 500 | Foreign Large Growth |
---|
1 Month | 2.66% | -1.30% | 0.68% |
---|
3 Month | 3.98% | -0.97% | 2.60% |
---|
Year-to-Date | 7.81% | 1.44% | 6.00% |
---|
1 Year | 5.88% | 18.41% | 6.98% |
---|
3 Year | 4.26% | 12.55% | 3.51% |
---|
5 Year | 6.65% | 16.85% | 6.92% |
---|
10 Year | 5.22% | 12.98% | 5.79% |
---|
Since Inception | 5.33% | 11.12% | -- |
---|
Sector Allocation - CIVBX
as of 02/28/2025
Basic Materials | | 4.85% |
---|
Consumer Cyclical | | 7.53% |
---|
Financial Services | | 15.34% |
---|
Real Estate | | 0.00% |
---|
Consumer Defensive | | 8.39% |
---|
Healthcare | | 12.03% |
---|
Utilities | | 2.23% |
---|
Communication Services | | 4.30% |
---|
Energy | | 2.94% |
---|
Industrials | | 25.41% |
---|
Technology | | 16.97% |
---|
Asset Allocation - CIVBX
as of 02/28/2025
By Percent | Short | 0% | Long | Net |
---|
Stock | -- | | | 0.73 | 0.73 |
---|
Bond | -- | | | 0.00 | 0.00 |
---|
Other | -- | | | 0.00 | 0.00 |
---|
Foreign Stock | -- | | | 95.71 | 95.71 |
---|
Foreign Bond | -- | | | 0.00 | 0.00 |
---|
Total | -- | | | 96.44 | 96.44 |
---|
Cash | -- | | | 3.56 | 3.56 |
---|
Total Net Assets | $2.11B |
---|
Total Stock Holdings | 124 |
---|
Total Bond Holdings | 0 |
---|
Top Ten Holdings - CIVBX
as of 02/28/2025
Company | YTD Return | % of Assets |
---|
SAP SE | -- | 3.29% |
---|
Novo Nordisk AS Class B | -- | 2.77% |
---|
Safran SA | -- | 2.74% |
---|
London Stock Exchange Group PLC | -- | 2.42% |
---|
AstraZeneca PLC | -- | 2.37% |
---|
ASML Holding NV | -- | 2.33% |
---|
TSM | -- | 2.15% |
---|
TotalEnergies SE | -- | 2.03% |
---|
Essilorluxottica | -- | 1.93% |
---|
ABB Ltd | -- | 1.79% |
---|
Valuation & Growth - CIVBX
as of 02/28/2025
Valuation | CIVBX | Category Range |
---|
Price/Earnings | 20.73 | |
---|
Price/Book | 2.97 | |
---|
Price/Sales | 2.42 | |
---|
Price/Cash Flow | 14.00 | |
---|
Dividend Yield | 2.4 | |
---|
LT Earnings | 9.77 | |
---|
Historical Earnings | 23.27 | |
---|
Sales Growth | 9.91 | |
---|
Cash-Flow Growth | 6.22 | |
---|
Book-Value Growth | 7.23 | |
---|